Perspectives for a new drug candidate for Chagas disease therapy.

Authors:
Soeiro MNC.

Journal:
Mem Inst Oswaldo Cruz

Publication Year: 2022

DOI:
10.1590/0074-02760220004

PMCID:
PMC8923671

PMID:
35293439

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Mem Inst Oswaldo Cruz

Abbreviation: Mem Inst Oswaldo Cruz

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Tropical Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Different profiles of chemokines, cytokines and cell growth factors in plasma samples from patients…
de Carvalho JC; Pascoal-Xavier MA; Araújo MG and 5 more (2024) - Transparency Score: 2/6
Animal models and SARS-CoV-2-induced pulmonary and neurological injuries.
Pinto MA; da Silva ADS; Rodrigues DDRF and 5 more (2023) - Transparency Score: 2/6
An increased number of individuals of a potential host facilitates non-photic synchronisation in th…
Valentinuzzi/ VS; Abrahan LB. (2023) - Transparency Score: 2/6
Anxiety, depression, and memory loss in Chagas disease: a puzzle far beyond neuroinflammation to be…
Lannes-Vieira J; Vilar-Pereira G; Barrios LC and 1 more (2023) - Transparency Score: 2/6
A review of serological tests available in Brazil for intestinal schistosomiasis diagnosis.
Ramos LMDS; da Silva-Pereira RA; Oliveira E and 2 more (2023) - Transparency Score: 2/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"MNCS conducted the review and drafted the original version and finalised the manuscript. The author approved the final version of the manuscript and declare that there are no conflicts of interest related to the content of this article."

Evidence found in paper:

"Financial support: Grants from FAPERJ, CNPq, PAEF, FIOCRUZ. MNCS is research fellow of the CNPq and Cientista do Nosso Estado da FAPERJ."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025